- Home
- YQ vs CDIO Comparison
YQ vs CDIO Comparison
Compare YQ & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YQ
- CDIO
- Stock Information
- Founded
- YQ 2012
- CDIO 2017
- Country
- YQ China
- CDIO United States
- Employees
- YQ N/A
- CDIO N/A
- Industry
- YQ Other Consumer Services
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- YQ Real Estate
- CDIO Health Care
- Exchange
- YQ Nasdaq
- CDIO Nasdaq
- Market Cap
- YQ 13.1M
- CDIO 12.3M
- IPO Year
- YQ 2020
- CDIO N/A
- Fundamental
- Price
- YQ $1.63
- CDIO $0.90
- Analyst Decision
- YQ
- CDIO Buy
- Analyst Count
- YQ 0
- CDIO 1
- Target Price
- YQ N/A
- CDIO $2.00
- AVG Volume (30 Days)
- YQ 42.7K
- CDIO 12.3M
- Earning Date
- YQ 12-11-2024
- CDIO 11-13-2024
- Dividend Yield
- YQ N/A
- CDIO N/A
- EPS Growth
- YQ N/A
- CDIO N/A
- EPS
- YQ N/A
- CDIO N/A
- Revenue
- YQ $28,507,378.00
- CDIO $35,688.00
- Revenue This Year
- YQ N/A
- CDIO $2,093.61
- Revenue Next Year
- YQ N/A
- CDIO $43.05
- P/E Ratio
- YQ N/A
- CDIO N/A
- Revenue Growth
- YQ 22.55
- CDIO 180.90
- 52 Week Low
- YQ $1.47
- CDIO $0.19
- 52 Week High
- YQ $3.55
- CDIO $3.56
- Technical
- Relative Strength Index (RSI)
- YQ 31.56
- CDIO 58.19
- Support Level
- YQ $1.50
- CDIO $0.99
- Resistance Level
- YQ $1.92
- CDIO $1.77
- Average True Range (ATR)
- YQ 0.20
- CDIO 0.27
- MACD
- YQ -0.01
- CDIO 0.04
- Stochastic Oscillator
- YQ 16.13
- CDIO 41.73
About YQ 17 Education & Technology Group Inc.
17 Education & Technology Group Inc is an education technology company in China. It offers to assist students, teachers, schoolmasters, and educational authorities across China to achieve data-driven teaching, learning, and assessment. Geographically group operates in China.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.